Taken together, this line of evidence strongly supports our findings of a role for GRK2 as an earlier marker in AD pathogenesis and may couple the contribution of oxidative stress, NO, eNOS, and ET-1 to the pathobiology of AD (Figure 6). Here, NOS3 is linked to Alzheimer disease.